The historical rank and industry rank for AstraZeneca Pharma India's Days Inventory or its related term are showing as below:
NSE:ASTRAZEN'
s Days Inventory Range Over the Past 10 Years
Min: 113.33 Med: 150.15 Max: 208.32
Current: 207.5
During the past 13 years, AstraZeneca Pharma India's highest Days Inventory was 208.32. The lowest was 113.33. And the median was 150.15.
NSE:ASTRAZEN's Days Inventory is ranked worse than 66.74% of 917
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:ASTRAZEN: 207.50
Inventory Turnover measures how fast the company turns over its inventory within a year.
AstraZeneca Pharma India's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.38.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
AstraZeneca Pharma India's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.78.
AstraZeneca Pharma India (NSE:ASTRAZEN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
AstraZeneca Pharma India's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
AstraZeneca Pharma India's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
AstraZeneca Pharma India Days Inventory Related Terms
AstraZeneca Pharma India Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTRAZEN vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AstraZeneca Pharma India Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's Days Inventory distribution charts can be found below:
* The bar in red indicates where AstraZeneca Pharma India's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AstraZeneca Pharma India (NSE:ASTRAZEN) has a Days Inventory of 237.78 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AstraZeneca Pharma India and its competitors. This is 58% above median its historical median of 150.15. Over the past decade, AstraZeneca Pharma India's Days Inventory has ranged from 113.33 to 208.32. According to the industry distribution chart, AstraZeneca Pharma India ranks #612 out of 917 companies in the Drug Manufacturers industry, placing it in the top 66.7%.
Is AstraZeneca Pharma India's Days Inventory too high?
AstraZeneca Pharma India's current Days Inventory of 237.78 is 58% above median its 10-year median of 150.15. Over the past 10 years, this metric has ranged from a low of 113.33 to a high of 208.32. The Drug Manufacturers industry median Days Inventory is 164.48. AstraZeneca Pharma India's value of 237.78 is 44.6% above this industry median. Based on the distribution chart, AstraZeneca Pharma India ranks #612 out of 917 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, AstraZeneca Pharma India has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca Pharma India's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, AstraZeneca Pharma India ranks #612 out of 917 companies for Days Inventory. This places AstraZeneca Pharma India in the lower half of its industry. The industry median Days Inventory is 164.48. AstraZeneca Pharma India's value of 237.78 is 44.6% above this benchmark. Historically, AstraZeneca Pharma India's own Days Inventory has ranged from 113.33 to 208.32 over the past decade. While the company's 10-year median is 150.15 vs. the industry median of 164.48, AstraZeneca Pharma India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AstraZeneca Pharma India's current Days Inventory of 237.78 is 44.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AstraZeneca Pharma India and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AstraZeneca Pharma India's current Days Inventory is 237.78, which is 58% above median its own 10-year median of 150.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca Pharma India stock overvalued right now?
Based on GuruFocus' analysis, AstraZeneca Pharma India (NSE:ASTRAZEN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹10,902.68, compared to a current price of ₹8,176.50 — trading 25% below its estimated fair value. The current Days Inventory is 237.78, which is 58% above median its 10-year median of 150.15 and 44.6% above the Drug Manufacturers industry median of 164.48. AstraZeneca Pharma India's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For AstraZeneca Pharma India (NSE:ASTRAZEN), the current Days Inventory is 237.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AstraZeneca Pharma India (NSE:ASTRAZEN) Overvalued in 2026?
Based on GuruFocus' analysis, AstraZeneca Pharma India stock appears to be undervalued.
The current stock price of ₹8,176.50 is trading 25% below its estimated GF Value™ of ₹10,902.68.
GuruFocus considers AstraZeneca Pharma India to be Modestly Undervalued.
Key valuation signals for NSE:ASTRAZEN:
Days Inventory: 237.78 (58% above median its 10-year median of 150.15)
GF Value™: ₹10,902.68 vs. price of ₹8,176.50 (25% below fair value)
Industry Position: 44.6% above the Drug Manufacturers median (#612 of 917)
No single metric tells the full story. See the NSE:ASTRAZEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines. The company operates within India, and outside, like Cambridge, Gothenburg, and Gaithersburg. The majority of revenue is from India.
92GF Score
Get the complete analysis for NSE:ASTRAZEN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTRAZEN has been successfully added to your 
